Kohrman Daniel B
Foundation Litigation, 601 E Street NW, Rm. B4-454, Washington DC 20015, USA.
J Diabetes Sci Technol. 2013 Mar 1;7(2):350-5. doi: 10.1177/193229681300700210.
Safety issues posed by driving with diabetes are primarily related to severe hypoglycemia, yet some public authorities rely on categorical restrictions on drivers with diabetes. This approach is misguided. Regulation of all drivers with diabetes, or all drivers using insulin, ignores the diversity of people with diabetes and fails to focus on the subpopulation posing the greatest risk. Advances in diabetes care technology and understanding of safety consequences of diabetes have expanded techniques available to limit risks of driving with diabetes. New means of insulin administration and blood glucose monitoring offer greater ease of anticipating and preventing hypoglycemia, and thus, limit driving risk for persons with diabetes. So too do less sophisticated steps taken by people with diabetes and the health care professionals they consult. These include adoption and endorsement of safety-sensitive behaviors, such as testing before a drive and periodic testing on longer trips. Overall, and in most individual cases, driving risks for persons with diabetes are less than those routinely tolerated by our society. Examples include freedom to drive in dangerous conditions and lax regulation of drivers in age and medical cohorts with elevated overall rates of driving mishaps. Data linking specific diabetes symptoms or features with driving risk are quite uncertain. Hence, there is much to recommend: a focus on technological advances, human precautions, and identifying individuals with diabetes with a specific history of driving difficulty. By contrast, available evidence does not support unfocused regulation of all or most drivers with diabetes.
糖尿病患者驾车带来的安全问题主要与严重低血糖有关,但一些公共当局却对糖尿病患者采取绝对限制措施。这种做法是错误的。对所有糖尿病患者或所有使用胰岛素的驾驶者进行监管,忽视了糖尿病患者的多样性,也未能关注风险最大的亚群体。糖尿病护理技术的进步以及对糖尿病安全后果的认识,拓展了限制糖尿病患者驾车风险的可用技术。新的胰岛素给药方式和血糖监测手段,使预测和预防低血糖更加容易,从而降低了糖尿病患者的驾车风险。糖尿病患者及其咨询的医护人员采取的一些不太复杂的措施也能起到同样的效果。这些措施包括采用并认可安全敏感行为,如开车前检测以及在长途旅行中定期检测。总体而言,在大多数情况下,糖尿病患者的驾车风险低于我们社会通常容忍的风险。例如,允许在危险条件下驾驶,以及对交通事故总体发生率较高的年龄和医疗群体的驾驶者监管宽松。将特定糖尿病症状或特征与驾车风险联系起来的数据非常不确定。因此,有很多值得推荐的做法:关注技术进步、个人预防措施,以及识别有特定驾车困难病史的糖尿病患者。相比之下,现有证据并不支持对所有或大多数糖尿病患者进行无针对性的监管。